Compare PINE & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PINE | MASS |
|---|---|---|
| Founded | 2019 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 352.2M | 326.0M |
| IPO Year | 2019 | 2020 |
| Metric | PINE | MASS |
|---|---|---|
| Price | $19.98 | $8.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $20.10 | $12.00 |
| AVG Volume (30 Days) | 144.2K | ★ 268.0K |
| Earning Date | 04-23-2026 | 05-12-2026 |
| Dividend Yield | ★ 6.29% | N/A |
| EPS Growth | N/A | ★ 125.47 |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $60,532,000.00 | $56,197,000.00 |
| Revenue This Year | $18.63 | $19.44 |
| Revenue Next Year | N/A | $18.63 |
| P/E Ratio | $86.78 | ★ N/A |
| Revenue Growth | ★ 15.90 | N/A |
| 52 Week Low | $13.10 | $5.03 |
| 52 Week High | $21.99 | $9.34 |
| Indicator | PINE | MASS |
|---|---|---|
| Relative Strength Index (RSI) | 43.32 | 57.90 |
| Support Level | $19.88 | $7.57 |
| Resistance Level | $21.22 | $8.36 |
| Average True Range (ATR) | 0.66 | 0.44 |
| MACD | -0.12 | 0.15 |
| Stochastic Oscillator | 10.57 | 72.16 |
Alpine Income Property Trust Inc is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties in the United States. The company's portfolio predominantly comprises single-tenant retail properties located in or near metropolitan statistical areas, or MSAs. It operates in two business segments: income properties, which derive maximum revenue, and commercial loans and investments.
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.